Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony S Mok

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Respirology (Carlton, Vic.)|August 21, 2010
Targeted therapy: an evolving world of lung cancerKwok-Chi Lam, Tony S Mok
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Research and standard care: lung cancer in chinaTony S Mok, Qing Zhou, Yi-Long Wu
Expert Review of Anticancer Therapy|October 15, 2010
Personalized medicine for non-small-cell lung cancerTony S Mok, Qing Zhou, Linda Leung, et al.
Cancer Treatment Reviews|November 29, 2011
EGFR-mutated oncogene-addicted non-small cell lung cancer: current trends and future prospectsJean-Charles Soria, Tony S Mok, Federico Cappuzzo, et al.
Lung Cancer (Amsterdam, Netherlands)|January 29, 2011
Lung cancer in never smokers: change of a mindset in the molecular eraYoung Joo Lee, Joo-Hang Kim, Se Kyu Kim, et al.
Pathology Oncology Research : POR|April 22, 2009
Clinicopathologic and molecular features of epidermal growth factor receptor T790M mutation and c-MET amplification in tyrosine kinase inhibitor-resistant Chinese non-small cell lung cancerHua-Jun Chen, Tony S Mok, Zhi-Hong Chen, et al.
The Lancet. Oncology|November 3, 2009
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009Ross A Soo, Benjamin O Anderson, Byoung Chul Cho, et al.
Future Oncology (London, England)|April 21, 2012
Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapyRoss A Soo, Tomoya Kawaguchi, Marie Loh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: results of a meta-analysis of randomized controlled trialsRoss A Soo, Marie Loh, Tony S Mok, et al.
Future Oncology (London, England)|March 7, 2019
Management of common adverse events related to first-line dacomitinib use in <i>EGFR</i> mutation-positive non-small-cell lung cancer: a pooled safety analysisQing Zhou, Yi-Long Wu, Jesus Corral, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Respirology (Carlton, Vic.)|August 21, 2010
Targeted therapy: an evolving world of lung cancerKwok-Chi Lam, Tony S Mok
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Research and standard care: lung cancer in chinaTony S Mok, Qing Zhou, Yi-Long Wu
Expert Review of Anticancer Therapy|October 15, 2010
Personalized medicine for non-small-cell lung cancerTony S Mok, Qing Zhou, Linda Leung, et al.
Cancer Treatment Reviews|November 29, 2011
EGFR-mutated oncogene-addicted non-small cell lung cancer: current trends and future prospectsJean-Charles Soria, Tony S Mok, Federico Cappuzzo, et al.
Lung Cancer (Amsterdam, Netherlands)|January 29, 2011
Lung cancer in never smokers: change of a mindset in the molecular eraYoung Joo Lee, Joo-Hang Kim, Se Kyu Kim, et al.
Pathology Oncology Research : POR|April 22, 2009
Clinicopathologic and molecular features of epidermal growth factor receptor T790M mutation and c-MET amplification in tyrosine kinase inhibitor-resistant Chinese non-small cell lung cancerHua-Jun Chen, Tony S Mok, Zhi-Hong Chen, et al.
The Lancet. Oncology|November 3, 2009
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009Ross A Soo, Benjamin O Anderson, Byoung Chul Cho, et al.
Future Oncology (London, England)|April 21, 2012
Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapyRoss A Soo, Tomoya Kawaguchi, Marie Loh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: results of a meta-analysis of randomized controlled trialsRoss A Soo, Marie Loh, Tony S Mok, et al.
Future Oncology (London, England)|March 7, 2019
Management of common adverse events related to first-line dacomitinib use in <i>EGFR</i> mutation-positive non-small-cell lung cancer: a pooled safety analysisQing Zhou, Yi-Long Wu, Jesus Corral, et al.
Pageof 5